Technical Analysis for AVTX - Avalo Therapeutics, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Up | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Crossed Above 20 DMA | Bullish | 0.00% | |
| Inside Day | Range Contraction | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Up 3 Days in a Row | Strength | 0.00% | |
| Up 4 Days in a Row | Strength | 0.00% | |
| Up 5 Days in a Row | Strength | 0.00% | |
| 20 DMA Resistance | Bearish | 6.41% | |
| Pocket Pivot | Bullish Swing Setup | 6.41% | |
| Wide Bands | Range Expansion | 6.41% | |
| Up 3 Days in a Row | Strength | 6.41% |
| Alert | Time |
|---|---|
| 60 Minute Opening Range Breakout | about 13 hours ago |
| Possible NR7 | about 14 hours ago |
| Possible Inside Day | about 14 hours ago |
| 60 Minute Opening Range Breakdown | about 15 hours ago |
| 20 DMA Support | about 17 hours ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/02/2024
Avalo Therapeutics is a leading clinical-stage precision medicine company that discovers, develops, and commercializes targeted therapeutics for patients with significant unmet clinical need in immunology, immuno-oncology, and rare genetic diseases. The company has built a diverse portfolio of innovative therapies to deliver meaningful medical impact for patients in urgent need. The company’s clinical candidates commonly have a proven mechanistic rationale, biomarkers and/or an established proof-of-concept to expedite and increase the probability of success.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biology Cancer Immunotherapy Biomarkers Precision Medicine Targeted Therapy Innovative Therapies Rare Genetic Diseases
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biology Cancer Immunotherapy Biomarkers Precision Medicine Targeted Therapy Innovative Therapies Rare Genetic Diseases
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 1130.4 |
| 52 Week Low | 3.9501 |
| Average Volume | 833,089 |
| 200-Day Moving Average | 21.30 |
| 50-Day Moving Average | 9.08 |
| 20-Day Moving Average | 14.76 |
| 10-Day Moving Average | 13.88 |
| Average True Range | 2.35 |
| RSI (14) | 61.98 |
| ADX | 41.77 |
| +DI | 40.51 |
| -DI | 17.01 |
| Chandelier Exit (Long, 3 ATRs) | 27.42 |
| Chandelier Exit (Short, 3 ATRs) | 11.64 |
| Upper Bollinger Bands | 17.94 |
| Lower Bollinger Band | 11.58 |
| Percent B (%b) | 0.69 |
| BandWidth | 43.11 |
| MACD Line | 1.37 |
| MACD Signal Line | 1.62 |
| MACD Histogram | -0.2495 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 18.24 | ||||
| Resistance 3 (R3) | 18.08 | 17.15 | 17.86 | ||
| Resistance 2 (R2) | 17.15 | 16.57 | 17.23 | 17.73 | |
| Resistance 1 (R1) | 16.55 | 16.20 | 16.85 | 16.71 | 17.60 |
| Pivot Point | 15.62 | 15.62 | 15.77 | 15.70 | 15.62 |
| Support 1 (S1) | 15.01 | 15.03 | 15.32 | 15.17 | 14.28 |
| Support 2 (S2) | 14.08 | 14.67 | 14.16 | 14.15 | |
| Support 3 (S3) | 13.48 | 14.08 | 14.02 | ||
| Support 4 (S4) | 13.64 |
